P273-0715 Screening compound: 1-[3-(5-CYCLOBUTYL-1,2,4-OXADIAZOL-3-YL)PYRIDIN-2-YL]-N-[2-(MORPHOLIN-4-YL)ETHYL]PIPERIDINE-3-CARBOXAMIDE

P273-0715 Screening compound: 1-[3-(5-CYCLOBUTYL-1,2,4-OXADIAZOL-3-YL)PYRIDIN-2-YL]-N-[2-(MORPHOLIN-4-YL)ETHYL]PIPERIDINE-3-CARBOXAMIDE
P273-0715 Screening compound: 1-[3-(5-CYCLOBUTYL-1,2,4-OXADIAZOL-3-YL)PYRIDIN-2-YL]-N-[2-(MORPHOLIN-4-YL)ETHYL]PIPERIDINE-3-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound P273-0715
1-[3-(5-CYCLOBUTYL-1,2,4-OXADIAZOL-3-YL)PYRIDIN-2-YL]-N-[2-(MORPHOLIN-4-YL)ETHYL]PIPERIDINE-3-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P273-0715

Molecular Formula

C23H32N6O3 (C23 H32 N6 O3)

Compound Name

1-[3-(5-CYCLOBUTYL-1,2,4-OXADIAZOL-3-YL)PYRIDIN-2-YL]-N-[2-(MORPHOLIN-4-YL)ETHYL]PIPERIDINE-3-CARBOXAMIDE

IUPAC name

1-[3-(5-cyclobutyl-124-oxadiazol-3-yl)pyridin-2-yl]-N-[2-(morpholin-4-yl)ethyl]piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1c1ncccc1-c1noc(C2CCC2)n1)NCCN1CCOCC1

InChI

InChI=1S/C23H32N6O3/c30-22(25-9-11-28-12-14-31-15-13-28)18-6-3-10-29(16-18)21-19(7-2-8-24-21)20-26-23(32-27-20)17-4-1-5-17/h2,7-8,17-18H,1,3-6,9-16H2,(H,25,30)/t18-/m0/s1

InChI Key

RWJJCYNIMXVHQF-SFHVURJKSA-N

MDL Number (MFCD)

MFCD27571202

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.55

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.799

Distribution Coefficient, logD

0.668

Water Solubility, LogSw

-2.23

Polar Surface Area

80.680

Acid Dissociation Constant (pKa)

13.14

Base Dissociation Constant (pKb)

8.50

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

65.20

P273-0715 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with P273-0715 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P273-0715?
Check Price and Availability of P273-0715, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P273-0715 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P273-0715
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P273-0715
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P273-0715 available by request